NIFTY
92.50  0.82%
 11397.55
S&P BSE SENSEX
335.92  0.88%
 38463
Biocon Ltd.
NSE : BIOCON BSE : 532523 ISIN code : INE376G01013
on 14-Oct-2019 14:04
NSE
0.55    0.22%
Rs. 248.15
 
Days Low
Rs. 245.25
Days High
Rs. 249.65

Open Rs. 249.5
 
52 week Low
Rs. 211.3
52 week High
Rs.341.5
 
 
Bid :                 248.15 (116)
Offer :        248.35 (291)
BSE
Rs.248.15
0.65    0.26%
on 14-Oct-2019 14:16
BSE
0.65    0.26%
Rs. 248.15
 
Days Low
Rs. 245
Days High
Rs. 249.9

Open Rs. 248
 
52 week Low
Rs. 211.05
52 week High
Rs.341.85
 
 
Bid :                 248.15 (116)
Offer :        248.35 (291)
NSE
Rs.248.15
0.55    0.22%
 
 
Last Price (Rs.)  248.15 Value  22410922.80
Net Change (Rs.)  0.65 Best Buy  248.15
Volume  90312 Best Sell  248.35
Prev.Close (Rs.)  247.50 Best Quantity  116
Open (Rs.)  249.50 Sell Quantity  291
High (Rs.)  249.65 52-Week High (Rs.)  341.50
Low (Rs.)  245.25 52-Week Low (Rs.)  211.30
Face Value (Rs.)  5 Market Cap.(Rs/ Mn)  297780.00
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital3000.00 3000.00 1000.00 
Share Capital3000.00 3000.00 1000.00 
Share Capital3000.00 3000.00 1000.00 
Share Capital3000.00 3000.00 1000.00 
Share Capital3000.00 3000.00 1000.00 
Currents Investments1134.00 4538.00 5247.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 397.45 953616 98.39 116.78 0.69
Divis Lab 1683.00 446784 272.75 33.52 0.95
Dr. Reddys Lab 2680.00 445271 791.64 34.83 0.75
Ranbaxy Labs. 859.90 366028 1.53 0.00 0.00
Cipla 441.55 355924 203.87 18.84 0.68
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Jun 2019Mar 2019Dec 2018
Net Sales4808.007639.007397.00
Operating Profit987.001124.001205.00
PBDT1802.001118.001197.00
Net Profit1119.00705.00727.00
More> 
 
Company News
10/11/2019 12:00:00 AM
Biocon’s arm, Just - Evotec Biologics sign licensing deal for biosimil...
10/11/2019 12:00:00 AM
Biocon gains as its arm and Just - Evotec Biologics sign licensing dea...
10/10/2019 12:00:00 AM
Announcement under Regulation 30 (LODR)-Press Release / Media Release
More>
 
Ratios
   Earnings Per Share (Rs)8.21 
   Book NAV/Share(Rs)117.59 
   PAT Margin (%)17.08 
   Asset Turnover(x)0.37 
   PER(x)37.20 
   Yield(%)0.16 
   EV/Core EBITDA(x)72.30 
   M Cap / Sales12.71 
   Net Sales Growth(%)19.24 
   PAT Growth(%)106.58 
   Total Debt/Equity(x)0.01 
   Current Ratio(x)2.46 
   Quick Ratio(x)1.72 
   Total Debt/Mcap(x)0.00 
More>